| Fahim Fahim, MD | |
|
3517 Brandon Ave Sw, Roanoke, VA 24018-1523 | |
| (540) 981-1102 | |
| (540) 344-4169 |
| Full Name | Fahim Fahim |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Child & Adolescent Psychiatry |
| Location | 3517 Brandon Ave Sw, Roanoke, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033183801 | NPI | - | NPPES |
| 081024 | Other | VA | SENTARA |
| 2182262 | Other | VA | CIGNA |
| 246008 | Other | VA | HEALTHKEEPERS |
| 004945263 | Medicaid | VA | |
| 246008 | Other | VA | ANTHEM |
| 537848000 | Other | VA | MEGALLAN |
| 4945263 | Other | VA | VIGINIA PREMIER |
| Entity Name | Mcv Associated Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710959457 PECOS PAC ID: 4385542117 Enrollment ID: O20031230000559 |
News Archive
Diabetes is a leading cause of kidney disease, a serious, often fatal complication that is difficult to diagnose in early, potentially treatable stages.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.
Many different variants and lineages have arisen from the ancestral Wuhan-Hu1 strain of the SARS-CoV-2. This requires careful attention to control measures since many are more infective and transmissible than the older strains. A recent study compares the UK variant of this virus with the wildtype in terms of susceptibility to routine cleaning and disinfection measures.
MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce significant enhancements to EMPOWER, the company's comprehensive investigator initiated - sponsored research management solution. The EMPOWER system is currently being utilized on a world-wide basis by numerous pharmaceutical and medical device companies to automate and streamline investigator research submissions, management and reporting.
In response to rising concern that many published scientific results may be false, the Reproducibility Project: Cancer Biology set out to replicate findings from the 50 most cited cancer studies from 2010-2012.
› Verified 7 days ago
| Entity Name | Blue Ridge Behavioral Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437137734 PECOS PAC ID: 6709831522 Enrollment ID: O20050315000430 |
News Archive
Diabetes is a leading cause of kidney disease, a serious, often fatal complication that is difficult to diagnose in early, potentially treatable stages.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.
Many different variants and lineages have arisen from the ancestral Wuhan-Hu1 strain of the SARS-CoV-2. This requires careful attention to control measures since many are more infective and transmissible than the older strains. A recent study compares the UK variant of this virus with the wildtype in terms of susceptibility to routine cleaning and disinfection measures.
MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce significant enhancements to EMPOWER, the company's comprehensive investigator initiated - sponsored research management solution. The EMPOWER system is currently being utilized on a world-wide basis by numerous pharmaceutical and medical device companies to automate and streamline investigator research submissions, management and reporting.
In response to rising concern that many published scientific results may be false, the Reproducibility Project: Cancer Biology set out to replicate findings from the 50 most cited cancer studies from 2010-2012.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Fahim Fahim, MD 301 Elm Ave Sw, Roanoke, VA 24016-4001 Ph: (540) 345-9841 | Fahim Fahim, MD 3517 Brandon Ave Sw, Roanoke, VA 24018-1523 Ph: (540) 981-1102 |
News Archive
Diabetes is a leading cause of kidney disease, a serious, often fatal complication that is difficult to diagnose in early, potentially treatable stages.
Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.
Many different variants and lineages have arisen from the ancestral Wuhan-Hu1 strain of the SARS-CoV-2. This requires careful attention to control measures since many are more infective and transmissible than the older strains. A recent study compares the UK variant of this virus with the wildtype in terms of susceptibility to routine cleaning and disinfection measures.
MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, is pleased to announce significant enhancements to EMPOWER, the company's comprehensive investigator initiated - sponsored research management solution. The EMPOWER system is currently being utilized on a world-wide basis by numerous pharmaceutical and medical device companies to automate and streamline investigator research submissions, management and reporting.
In response to rising concern that many published scientific results may be false, the Reproducibility Project: Cancer Biology set out to replicate findings from the 50 most cited cancer studies from 2010-2012.
› Verified 7 days ago
Dr. Badr Ratnakaran, MBBS Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-981-8025 Fax: 540-853-0511 | |
Carlos Mora, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-224-5170 Fax: 540-985-9427 | |
John H Draeger, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-853-0900 Fax: 540-853-0518 | |
Dr. John Eric Vance, M.D Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-853-0900 Fax: 540-853-0518 | |
Dr. John Gordon Burch, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4431 Starkey Rd, Roanoke, VA 24018 Phone: 540-342-0211 Fax: 540-344-5543 | |
Sooraj John, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2017 Jefferson St Sw, Roanoke, VA 24014 Phone: 540-981-8025 Fax: 540-853-0511 |